India Hyperactivity Disorder Therapeutics Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Hyperactivity Disorder Therapeutics Market was valued at USD 232.0 million in 2025 and is projected to reach USD 382.40 million by 2032, growing at a CAGR of approximately 7.4% during 2026–2032.
India Hyperactivity Disorder Therapeutics Market Highlights
| Report Metric | Details |
| Report Name | India Hyperactivity Disorder Therapeutics Market |
| Market Size 2025 | USD 232.0 million |
| Market Size 2032 | USD 382.40 million |
| Absolute Growth 2025–2032 | USD 150.40 million |
| CAGR 2026–2032 | 7.4% |
| Peak Annual Growth | 9.2% in 2030 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Drug Type, 2025 | Stimulants (44% share) |
| Leading Mechanism of Action, 2025 | CNS Activation (41% share) |
| Leading Age Group, 2025 | Children/Teens (43% share) |
| Leading End User, 2025 | Pediatric Clinics (36% share) |
| Fastest-Growing Drug Type | Combination Treatments (9.8% CAGR) |
| Fastest-Growing Age Group | Adults (9.1% CAGR) |
| Fastest-Growing End User | Mental Health Specialists (9.5% CAGR) |
| Growing Sector | Mental Health Specialists |
| Key End Users | Pediatric Clinics, Mental Health Specialists, Therapy Centers, Psychiatric Institutions |
India Hyperactivity Disorder Therapeutics Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 7.1 | The market experienced steady growth due to increasing awareness of ADHD among parents and educators. |
| 2023 | 6.3 | Awareness campaigns faced challenges in reaching rural populations effectively, slowing growth. |
| 2024 | 5.8 | Demand continued to rise, but limited access to mental health resources in some regions affected the pace. |
| 2025 | 8.7 | Growth accelerated as pediatric clinics reported a surge in ADHD diagnoses and treatment requests. |
| 2026 | 6.7 | The market is expected to see a slowdown due to delays in medication availability in the supply chain. |
| 2027 | 8.0 | Improved access to ADHD therapeutics in urban healthcare facilities will drive growth again. |
| 2028 | 6.4 | A slowdown is projected as the focus shifts to integrating behavioral therapies into treatment plans. |
| 2029 | 8.3 | Demand is expected to increase as mental health specialists expand their services to include management of ADHD. |
| 2030 | 9.2 | The market will peak with heightened investment in ADHD awareness and treatment programs across the country. |
| 2031 | 7.9 | Growth is projected to slow as the market begins to stabilise following the peak in treatment uptake. |
| 2032 | 5.3 | The market is expected to continue growing, but at a moderated pace as awareness efforts reach saturation. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Hyperactivity Disorder Therapeutics Market Synopsis
The market for Hyperactivity Disorder Therapeutics in India encompasses medications and behavioral therapies aimed at managing ADHD. These products are designed to improve focus and reduce impulsivity in affected individuals. With approximately 20 million children diagnosed with ADHD, the India Hyperactivity Disorder Therapeutics Market is expanding rapidly. The rise in awareness campaigns and support from healthcare initiatives are driving demand for these therapeutics, particularly in urban areas where access to treatment is improving. Pediatric clinics play a key role in this growth, as they are increasingly diagnosing and treating ADHD cases.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing awareness of ADHD symptoms and treatment options drives demand for therapeutics. | Driver | High | Stimulants |
| The growing number of pediatric clinics enhances access to ADHD treatments. | Driver | High | Pediatric Clinics |
| The gap in comprehensive ADHD treatment options presents opportunities for new therapies. | Opportunity | High | Behavioral Therapies |
| The rise in adult ADHD cases creates demand for tailored treatment solutions. | Opportunity | Medium | Adults |
| Limited access to mental health services in rural areas restricts treatment availability. | Restraint | High | Non-Stimulants |
| The complexity of ADHD treatment protocols can lead to inconsistent care. | Restraint | Medium | Combination Treatments |
| High costs of advanced therapies may deter patients from seeking treatment. | Challenge | High | Drug + Therapy |
| Delays in regulatory approvals for new medications can slow market growth. | Challenge | Medium | CNS Activation |
Evaluation of Drivers in India Hyperactivity Disorder Therapeutics Market (2026–2032)
The main growth drivers and the segments they affect most are set out below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising awareness of ADHD among parents and educators increases prescriptions. | Stimulants | Around 20 million children diagnosed with ADHD are driving higher demand for medications. |
| Expansion of pediatric clinics improves access to ADHD treatments. | Pediatric Clinics | Urban pediatric clinics report a rising number of ADHD cases annually, prompting increased treatment availability. |
| Integration of behavioral therapies into treatment plans increases overall effectiveness. | Behavioral Therapies | The Indian Academy of Pediatrics recommends behavioral therapies as essential for ADHD management. |
| The increase in adult ADHD recognition expands the market for therapeutics. | Adults | Growing awareness of ADHD in adults is resulting in more treatment inquiries and prescriptions. |
| Research initiatives on ADHD treatments are creating new therapeutic options. | Combination Treatments | The National Institute of Mental Health and Neurosciences conducts research that informs treatment developments. |
Market growth for Hyperactivity Disorder Therapeutics in India is underpinned by rising awareness of ADHD among parents and educators, alongside the expansion of pediatric clinics. Approximately 20 million children are diagnosed with ADHD, which is increasing prescriptions for stimulant medications, accounting for around 60% of ADHD prescriptions. The integration of behavioral therapies into treatment plans is gaining traction, as recommended by the Indian Academy of Pediatrics. Recognition of adult ADHD is expanding the market, with more adults seeking treatment options.
Evaluation of Restraints in India Hyperactivity Disorder Therapeutics Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to mental health services in rural areas restricts treatment availability. | Non-Stimulants | Approximately 20 million children diagnosed with ADHD face challenges in accessing necessary treatments due to geographical barriers. |
| The complexity of ADHD treatment protocols can lead to inconsistent care. | Combination Treatments | Inconsistent application of treatment guidelines across different clinics affects patient outcomes. |
| High costs of advanced therapies may deter patients from seeking treatment. | Drug + Therapy | Patients may avoid necessary treatments due to financial constraints, impacting overall market growth. |
| Delays in regulatory approvals for new medications can slow market growth. | CNS Activation | Lengthy approval processes hinder the introduction of new ADHD treatments into the market. |
| Limited awareness of ADHD symptoms among parents and educators affects diagnosis rates. | Behavioral Therapies | A lack of understanding can lead to underdiagnosis and delayed treatment for affected children. |
India Hyperactivity Disorder Therapeutics Market Challenges
Families managing Hyperactivity Disorder Therapeutics in India face increasing costs, as stimulant medications represent around 60% of prescriptions, putting pressure on household budgets. Limited access to advanced diagnostic technologies in many urban clinics delays effective treatment, prolonging symptoms in affected children and impacting their academic performance. Competition from both domestic and imported therapeutic options creates confusion among parents, complicating their decision-making process and potentially hindering timely care. A shortage of trained mental health professionals affects service quality, leaving many families without the necessary support for their children's treatment needs, which can lead to worsening conditions over time.
Trends in the India Hyperactivity Disorder Therapeutics Market
Buyers and suppliers in the India Hyperactivity Disorder Therapeutics Market are adjusting to the following trends.
- National Health Mission Improving Mental Health Services: The National Health Mission is enhancing mental health services for children, with a focus on ADHD treatment. Since 2019, initiatives have aimed to integrate mental health into primary healthcare, benefiting millions of children diagnosed with ADHD.
- Pediatric Clinics Increasing ADHD Diagnoses: Pediatric clinics in urban areas are increasingly diagnosing ADHD, responding to the growing awareness among parents. Reports indicate that these clinics are experiencing a notable rise in ADHD cases, with approximately 20 million children affected.
- Growing Demand for Behavioral Therapies: The demand for behavioural therapies is rising as they are recognised as important for ADHD management. The Indian Academy of Pediatrics has updated guidelines to promote these therapies, reflecting a shift towards effective treatment strategies.
- Focus on Adult ADHD Recognition: There is an increasing focus on recognising ADHD in adults, leading to a rise in treatment inquiries. This trend is supported by awareness campaigns that highlight the prevalence of ADHD symptoms in adult populations.
Investment Opportunities in the India Hyperactivity Disorder Therapeutics Market
Several openings in the India Hyperactivity Disorder Therapeutics Market merit attention from investors.
- Gap in Comprehensive ADHD Treatment: With approximately 20 million children diagnosed with ADHD, there is a gap in treatment options. Investing in new therapies can meet the needs of pediatric clinics, particularly in urban areas.
- Integration of Behavioral Therapies into Treatment Plans: The integration of behavioural therapies into ADHD treatment plans presents a strong opportunity. The Indian Academy of Pediatrics promotes these therapies, indicating a growing market for providers offering comprehensive solutions.
- Expansion of Services for Adult ADHD: The increasing recognition of adult ADHD creates opportunities for tailored treatment solutions. Providers can enter this market by collaborating with mental health specialists to offer specific therapies for adults.
- Training for Healthcare Professionals: There is a need for ongoing training for healthcare professionals in ADHD management. The National Institute of Mental Health and Neurosciences conducts annual training programs, presenting opportunities for educational institutions.
Government Initiatives in the India Hyperactivity Disorder Therapeutics Market
The Mental Health Care Act, 2017 mandates the provision of mental health services, including ADHD treatment, by all healthcare providers. This law ensures that ADHD therapeutics are accessible to all patients, improving overall treatment standards across India. The National Health Mission, updated in 2020, supports mental health initiatives for children and adolescents, aiming to improve ADHD care through various programs and funding opportunities. This initiative has led to increased awareness and improved access to necessary treatments for affected children.
The National Mental Health Programme, launched in 2021, aims to integrate mental health services into primary healthcare across India. This program is backed by the Ministry of Health and Family Welfare, which funds initiatives to improve mental health care for children. The National Institute of Mental Health and Neurosciences conducts annual training programs for healthcare professionals on ADHD management, ensuring that providers are equipped with the latest knowledge and skills to treat ADHD effectively. These training programs are crucial for improving the quality of care provided.
Future Insight of the India Hyperactivity Disorder Therapeutics Market
Several forward-looking factors should support the India Hyperactivity Disorder Therapeutics market in the coming years. Initiatives from the National Health Mission will increase awareness and access to essential treatments for families. Research from the National Institute of Mental Health and Neurosciences is expected to introduce new therapeutic options, benefiting millions of children diagnosed with hyperactivity disorders. The Indian Academy of Pediatrics' promotion of behavioural therapies will likely lead to broader acceptance and implementation of effective management strategies, ultimately improving outcomes for affected children.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Drug Type – Stimulants Dominated, Combination Treatments Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, Stimulants accounted for a 44% market share by drug type in 2025. Stimulants hold the largest share in the India Hyperactivity Disorder Therapeutics Market due to their widespread prescription for ADHD management, particularly in urban areas. With approximately 20 million children diagnosed with ADHD, the demand for stimulants continues to grow as they are the first-line treatment option. Combination Treatments are projected to grow fastest, at a CAGR of 9.8% during 2026–2032. Combination Treatments are experiencing rapid growth as they are increasingly prescribed for more severe cases of ADHD, reflecting a shift in treatment approaches. The rising awareness and diagnosis of ADHD in pediatric clinics further fuel this trend, leading to a broader acceptance of combination therapies. This trend indicates that suppliers should focus on developing and promoting combination treatment options to meet the evolving needs of healthcare providers.
By Mechanism of Action – CNS Activation Dominated and Is Expected to Record the Fastest Growth
With a 41% revenue share in 2025, CNS Activation was the largest mechanism of action category. CNS Activation leads the market share as it is the primary mechanism of action for stimulants, which are the most commonly prescribed medications for ADHD. This mechanism is well understood and trusted by healthcare professionals, ensuring its continued dominance in treatment protocols. The same category is also set to grow fastest, at a CAGR of 8.6% during 2026–2032. CNS Activation is also the fastest-growing mechanism due to its association with the increasing use of stimulants in ADHD therapy. As more clinicians recognise the efficacy of CNS activation in managing symptoms, its relevance in treatment plans will likely expand. Suppliers should emphasise the benefits of CNS activation in their marketing strategies to align with current treatment preferences.
By Age Group – Children/Teens Dominated, Adults Expected to Grow Fastest
The largest age group category in 2025 was Children/Teens, with a 43% share of total revenue. Children/Teens hold the largest market share as they represent the primary demographic affected by ADHD, with approximately 20 million diagnosed children in India. Initiatives by the Indian Psychiatric Society and the National Health Mission further underline the focus on this age group, ensuring continued demand for therapeutics. Over 2026–2032, Adults are expected to post the fastest growth, at a CAGR of 9.1%. Adults are experiencing the fastest growth in ADHD recognition, leading to increased diagnoses and treatment options. This rise is evidenced by changing perceptions and a growing awareness of ADHD symptoms in adults, which were previously overlooked, indicating a shift in understanding mental health. Suppliers should adapt their strategies to include products and marketing specifically aimed at adult patients to capture this expanding segment.
By End User – Pediatric Clinics Dominated, Mental Health Specialists Expected to Grow Fastest
Pediatric Clinics held a 36% share of the India Hyperactivity Disorder Therapeutics Market by end user in 2025. Pediatric Clinics hold the largest market share as they serve as the primary locations for diagnosing and treating ADHD, addressing the needs of millions of affected children in India. Their established presence and ongoing patient interactions solidify their importance in the ADHD therapeutics landscape. Mental Health Specialists are set to record the highest CAGR in this split, 9.5% over 2026–2032. Mental Health Specialists are experiencing the fastest growth due to their critical role in providing targeted ADHD therapeutics and behavioural therapies. The increasing awareness and diagnosis of ADHD among children are driving a surge in demand for their specialised services. This indicates that suppliers should prioritise collaborations with mental health specialists to effectively cater to the growing demand for ADHD management.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Hyperactivity Disorder Therapeutics Market Outlook
- Market Size of India Hyperactivity Disorder Therapeutics Market, 2025
- Forecast of India Hyperactivity Disorder Therapeutics Market, 2032
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Revenues & Volume for the Period 2022 - 2032F
- India Hyperactivity Disorder Therapeutics Market Trend Evolution
- India Hyperactivity Disorder Therapeutics Market Drivers and Challenges
- India Hyperactivity Disorder Therapeutics Price Trends
- India Hyperactivity Disorder Therapeutics Porter's Five Forces
- India Hyperactivity Disorder Therapeutics Industry Life Cycle
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Drug Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Stimulants for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Non-Stimulants for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Behavioral Therapies for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Combination Treatments for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Mechanism of Action for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By CNS Activation for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Norepinephrine Reuptake for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Cognitive Intervention for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Drug + Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Age Group for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Children/Teens for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Adults for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By All for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Adolescents for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Pediatric Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Mental Health Specialists for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Therapy Centers for the Period 2022 - 2032F
- Historical Data and Forecast of India Hyperactivity Disorder Therapeutics Market Revenues & Volume By Psychiatric Institutions for the Period 2022 - 2032F
- India Hyperactivity Disorder Therapeutics Import Export Trade Statistics
- Market Opportunity Assessment By Drug Type
- Market Opportunity Assessment By Mechanism of Action
- Market Opportunity Assessment By Age Group
- Market Opportunity Assessment By End User
- India Hyperactivity Disorder Therapeutics Top Companies Market Share
- India Hyperactivity Disorder Therapeutics Competitive Benchmarking By Technical and Operational Parameters
- India Hyperactivity Disorder Therapeutics Company Profiles
- India Hyperactivity Disorder Therapeutics Key Strategic Recommendations
Market Covered
The report offers an extensive study of the following market segments.
By Drug Type
- Stimulants
- Non-Stimulants
- Behavioral Therapies
- Combination Treatments
By Mechanism of Action
- CNS Activation
- Norepinephrine Reuptake
- Cognitive Intervention
- Drug + Therapy
By Age Group
- Children/Teens
- Adults
- All
- Adolescents
By End User
- Pediatric Clinics
- Mental Health Specialists
- Therapy Centers
- Psychiatric Institutions
